Skip to main content
Table of Contents
Print

Can Cannabis THC Regulate Ventilatory Drive During Sleep in Sleep Apnoea? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Maintaining adequate respiratory drive during sleep is critical for patients with sleep apnoea. Investigating THC for ventilatory drive offers insight into how cannabinoids might influence breathing patterns and stabilise nocturnal respiration. 

THC and Respiratory Regulation 

Studies suggest that THC for ventilatory drive may modulate central respiratory control, potentially improving the body’s response to airway obstruction and reducing apnoea events. 

Enhancing Respiratory Drive 

Respiratory drive with cannabinoids can be influenced by THC, which may help sustain consistent ventilation during sleep and prevent oxygen desaturation in sleep apnoea patients. 

Modulating Ventilatory Control 

Through ventilatory control with THC, cannabis may affect the sensitivity of central chemoreceptors, supporting more stable breathing patterns and improved oxygenation during apnoea episodes. 

Clinical Implications 

The use of THC for ventilatory drive may provide therapeutic benefit for patients experiencing frequent apnoea events. Optimising respiratory drive with cannabinoids could reduce the severity of nocturnal hypoxia and improve overall sleep quality. 

Early evidence indicates that THC for ventilatory drive may stabilise breathing in sleep apnoea by enhancing ventilatory control with THC and supporting respiratory drive with cannabinoids. Continued research is required to determine optimal dosing strategies and long-term safety for clinical use. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories